NURIX THERAPEUTICS INC (NRIX) Forecast, Price Target & Analyst Ratings

NASDAQ:NRIX • US67080M1036

Current stock price

16.81 USD
+0.11 (+0.66%)
At close:
16.48 USD
-0.33 (-1.96%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NURIX THERAPEUTICS INC (NRIX).

Forecast Snapshot

Consensus Price Target

Price Target
$31.01
+ 84.46% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 7, 2026
Period
Q2 / 2026
EPS Estimate
-$0.74
Revenue Estimate
17.649M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.09%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$31.01
Upside
+ 84.46%
From current price of $16.81 to mean target of $31.01, Based on 23 analyst forecasts
Low
$23.23
Median
$30.60
High
$43.05

Price Target Revisions

1 Month
1.33%
3 Months
2.54%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for NRIX. The average price target is 31.01 USD. This implies a price increase of 84.46% is expected in the next year compared to the current price of 16.81.
The average price target has been revised upward by 2.54% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NRIX Current Analyst RatingNRIX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

NRIX Historical Analyst RatingsNRIX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
86.09%
NRIX was analyzed by 23 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about NRIX.
In the previous month the buy percentage consensus was at a similar level.
NRIX was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-27HC Wainwright & Co.Reiterate Buy -> Buy
2026-04-23NeedhamReiterate Buy -> Buy
2026-04-10HC Wainwright & Co.Reiterate Buy -> Buy
2026-04-09Wells FargoMaintains Overweight -> Overweight
2026-04-08NeedhamReiterate Buy -> Buy
2026-03-24HC Wainwright & Co.Reiterate Buy -> Buy
2026-01-29BTIGReiterate Buy -> Buy
2026-01-29NeedhamReiterate Buy -> Buy
2026-01-29RBC CapitalMaintains Outperform -> Outperform
2026-01-29StifelMaintains Buy -> Buy
2026-01-29Wells FargoMaintains Overweight -> Overweight
2026-01-29Piper SandlerMaintains Overweight -> Overweight
2026-01-29HC Wainwright & Co.Maintains Buy -> Buy
2026-01-08Morgan StanleyUpgrade Equal-Weight -> Overweight
2025-12-16Wells FargoMaintains Overweight -> Overweight
2025-12-10MizuhoMaintains Outperform -> Outperform
2025-12-10HC Wainwright & Co.Maintains Buy -> Buy
2025-12-09BTIGMaintains Buy -> Buy
2025-12-08NeedhamReiterate Buy -> Buy
2025-11-04BTIGReiterate Buy -> Buy
2025-11-04NeedhamReiterate Buy -> Buy
2025-10-27HC Wainwright & Co.Maintains Buy -> Buy
2025-10-23BTIGMaintains Buy -> Buy
2025-10-23Wells FargoMaintains Overweight -> Overweight
2025-10-22NeedhamMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 7, 2026
Period
Q2 / 2026
EPS Estimate
-$0.74
Revenue Estimate
17.649M
Revenue Q2Q
-59.94%
EPS Q2Q
-41.36%
Number of Analysts
17

Next Earnings Revisions

Revenue (1 Month)
-5.28%
Revenue (3 Months)
0.14%
EPS (1 Month)
5.44%
EPS (3 Months)
13.82%

Next Earnings Summary

NRIX is expected to report earnings on 7/7/2026. The consensus EPS estimate for the next earnings is -0.74 USD and the consensus revenue estimate is 17.65M USD.
The next earnings revenue estimate has been revised upward by 0.14% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NRIX revenue by date.NRIX revenue by date.
76.987M
99.29%		54.549M
-29.15%		83.98M
53.95%		57.297M
-31.77%		84.831M
48.05%		141.3M
66.57%		267.38M
89.23%		500.75M
87.28%		775.76M
54.92%		1.171B
50.95%		1.621B
38.43%
EBITDA
YoY % growth
NRIX ebitda by date.NRIX ebitda by date.
-147.53M
17.36%		-203.709M
-38.08%		-276.926M
-35.94%		-355.963M
-28.54%		-388.719M
-9.20%		-303.363M
21.96%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
NRIX ebit by date.NRIX ebit by date.
-155.063M
15.67%		-213.027M
-37.38%		-285.666M
-34.10%		-358.186M
-25.39%		-381.779M
-6.59%		-342.181M
10.37%		-280.746M
17.95%		-86.029M
69.36%		162.95M
289.41%		598.3M
267.17%		1.014B
69.48%
Operating Margin
NRIX operating margin by date.NRIX operating margin by date.
-201.41%-390.52%-340.16%-625.14%-450.05%-242.17%-105.00%-17.18%21.01%51.09%62.55%
EPS
YoY % growth
NRIX eps by date.NRIX eps by date.
-2.65
28.95%		-2.89
-9.06%		-3.04
-5.19%		-3.11
-2.29%		-2.99
3.97%		-2.43
18.71%		-1.70
30.09%		-0.44
73.93%		1.30
394.67%		3.66
181.00%		6.15
67.80%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.74
-41.36%		-0.75
26.72%		-0.75
9.11%		-0.78
1.87%		-0.73
0.79%		-0.75
1.01%		-0.72
2.83%
Revenue
Q2Q % growth		17.649M
-59.94%		15.749M
99.51%		18.639M
37.28%		18.292M
192.58%		17.513M
-0.77%		19.142M
21.54%		18.643M
0.02%
EBITDA
Q2Q % growth		-84.267M
-92.70%		-87.689M
-3.45%		-89.653M
-20.57%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-86.505M
-79.02%		-89.876M
1.65%		-90.246M
-8.61%		-91.158M
1.45%		-90.959M
-5.15%		-93.022M
-3.50%		-92.992M
-3.04%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NRIX Yearly Revenue VS EstimatesNRIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
NRIX Yearly EPS VS EstimatesNRIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
6.31%
EPS Next 5 Year
13.15%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
17.57%
Revenue Next 5 Year
41.93%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-1.20%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NURIX THERAPEUTICS INC / NRIX Forecast FAQ

What is the average price target for NURIX THERAPEUTICS INC (NRIX) stock?

23 analysts have analysed NRIX and the average price target is 31.01 USD. This implies a price increase of 84.46% is expected in the next year compared to the current price of 16.81.

When does NURIX THERAPEUTICS INC (NRIX) report earnings?

NURIX THERAPEUTICS INC (NRIX) will report earnings on 2026-07-07.

Can you provide the consensus estimates for NURIX THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of NURIX THERAPEUTICS INC (NRIX) is -0.74 USD and the consensus revenue estimate is 17.65M USD.

What is the expected long term growth rate for NRIX stock?

The expected long term growth rate for NURIX THERAPEUTICS INC (NRIX) is 17.57%.